Navigation Links
Sun Yat-sen University and Johns Hopkins sign collaboration agreement
Date:3/4/2013

The training of next-generation clinical investigators in China is at the core of a new collaboration between Sun Yat-sen University (SYSU) and its affiliated hospitals in Guangzhou, China, and The Johns Hopkins University and Johns Hopkins Medicine International in Baltimore, USA.

The agreement between the academic medical centers was signed today in Guangzhou. It will provide a long-term platform for exchanges among clinical and translational investigators, research professionals and administrators in both countries, and will lay the foundation for building world-class research infrastructure in China, according to representatives of both institutions.

"China's health care sector and biomedical research field are growing rapidly," says Daniel Ford, M.D., M.P.H., professor and vice dean of clinical investigation at the Johns Hopkins University School of Medicine. "We are honored to have this opportunity to collaborate with SYSU and its affiliated hospitals to improve research processes, infrastructure and systems. We see this endeavor as a natural extension of Johns Hopkins Medicine's global mission and vision."

"We look forward to working with our colleagues at Johns Hopkins in the areas of clinical and translational research," says Ningsheng Xu, Ph.D., president of SYSU. "We firmly believe that this endeavor will become a milestone in the globalization of our university. The sharing of knowledge between our two institutions will help advance medical science and health care delivery in China, the United States and beyond."

In the first phase of the collaboration, Johns Hopkins experts will travel to SYSU to teach courses and lead workshops designed to strengthen development of investigators and research professionals. These experts also will design a competitive fellowship program at Johns Hopkins for promising SYSU investigators and junior faculty members, and provide strategic and technical advice on a wide range of issues that include research infrastructure, operations, safety and governance.

The agreement will also provide seed grants for collaborative clinical and translational pilot projects that have the potential to develop into larger studies funded by industry or government sources in China and the United States.

"This collaboration demonstrates our commitment to becoming a regional leader in clinical and translational research," says Mengfeng Li, Ph.D., vice president of SYSU and dean of SYSU's Zhongshan School of Medicine. "It is an opportunity for us to leverage Johns Hopkins' expertise in the discovery and application of the latest research advances. We are confident that the sooner we can enhance our training programs and research infrastructure, the sooner we can foster the kind of international collaborative research that will make a difference in people's lives in China and throughout the world."


'/>"/>

Contact: Natalia Abel
nboloti1@jhmi.edu
410-464-6645
Johns Hopkins Medicine
Source:Eurekalert

Related medicine news :

1. Members of University Services Sleep Diagnostic & Treatment Centers Wake Up Industries and Communities to the Importance of Sleep for Sleep Awareness Week
2. Book by University of Oregon psychologists opens eyes on betrayal
3. Case Western Reserve University joins BrainGate clinical trial
4. Baylor University researchers study barriers, resources to physical activity in Texas towns
5. Animal Cell Therapies, Inc. and University of Florida Receive $330k Grant from The Sabes Foundation for Stem Cell Study
6. Rice University analysis links ozone levels, cardiac arrest
7. NIKE Softball Camps Announces New Northeast Location at Bryant University
8. Quality Communication Solutions to Participate in Career Fair at Drake University in Des Moines, Iowa on February 14, 2013
9. Students in Educational First Steps Assisted Centers Show Persistent Benefits Far Beyond Early Childhood According to University of Texas at Dallas Study
10. University of Minnesota researchers discover enzyme behind breast cancer mutations
11. University of California Irvine, Medical Center Selects Jvion as their ICD-10 Risk Assessment and Crosswalk Provider
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... , ... March 29, 2017 , ... Immunotherapy has emerged ... number of cancers and is touted to be the next revolution in our fight ... has been in the form of immune checkpoint inhibitors such as PD-1 and PD-L1 ...
(Date:3/29/2017)... PA (PRWEB) , ... March 29, 2017 , ... The ... W’80, WG’81, and Julie Taffet Moelis, W’81, have made a $10 million gift to ... deferred admission opportunity that will provide a pathway to a Wharton MBA for highly-qualified ...
(Date:3/28/2017)... ... ... Tuesday, March 28, 2017, is the annual American Diabetes Association Alert Day, ... find out if they are at risk for developing Type 2 diabetes. In recognition ... by programming the LAX pylons the color red. Downtown’s U.S. Bank Tower Crown Lights ...
(Date:3/28/2017)... ... March 28, 2017 , ... Resoundant, Inc., the developer of ... Siemens Healthineers annual customer education symposium, a world-class learning conference that offers educational ... 27 - 31, 2017 at the Atlanta Marriott Marquis in Atlanta, Georgia. , ...
(Date:3/28/2017)... Seattle, WA (PRWEB) , ... March 28, 2017 ... ... reach a 22% share of all holidays (IBT World Travel Trends Report). As ... physically challenging, include a range in temperatures, and prolonged sun exposure. In response, ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... Research and Markets has announced the addition of the ... their offering. ... The ablation device global market is expected to grow at high ... Ablation is the minimally invasive therapeutic tissue excision procedure used ... removal, to the removal of abnormally conducting cardiac tissue in atrial ...
(Date:3/29/2017)... SAN FRANCISCO , March 29, 2017 /PRNewswire/ ... an option agreement with Bionure Farma, S.L. for ... BN201 and to BN119 in the field of ... million plus sales-based royalties. The agreement provides ... stage assets with a differentiated product profile. Under ...
(Date:3/29/2017)... 29, 2017   Royal Philips (NYSE: ... technology, and PathAI, a company that develops artificial ... aim to develop solutions that improve the precision ... other diseases. The partnership aims to build deep ... of artificial intelligence to be applied to massive ...
Breaking Medicine Technology: